STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 83 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 6.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $51,000 | -61.1% | 10,612 | -13.9% | 0.00% | – |
| Q4 2019 | $131,000 | 0.0% | 12,328 | -1.9% | 0.00% | – |
| Q3 2019 | $131,000 | -24.3% | 12,571 | +16.4% | 0.00% | – |
| Q2 2018 | $173,000 | +7.5% | 10,803 | +2.7% | 0.00% | – |
| Q1 2018 | $161,000 | -4.7% | 10,523 | -3.0% | 0.00% | – |
| Q4 2017 | $169,000 | -29.0% | 10,846 | -34.1% | 0.00% | – |
| Q1 2015 | $238,000 | -13.8% | 16,457 | +1.9% | 0.00% | -100.0% |
| Q4 2014 | $276,000 | – | 16,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 1,471,518 | $23,618,000 | 8.40% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 492,930 | $7,862,000 | 3.02% |
| Consonance Capital Management LP | 2,747,198 | $44,093,000 | 2.84% |
| NEXTHERA CAPITAL LP | 559,517 | $8,980,000 | 1.39% |
| Eventide Asset Management | 1,086,400 | $17,437,000 | 0.72% |
| Virtus ETF Advisers LLC | 45,850 | $736,000 | 0.65% |
| KNOTT DAVID M | 90,000 | $1,445,000 | 0.54% |
| Polar Capital LLP | 1,912,605 | $30,697,000 | 0.18% |
| Artal Group S.A. | 400,000 | $6,420,000 | 0.14% |
| J. Goldman & Co LP | 100,000 | $1,605,000 | 0.08% |